This Week in Virology

TWiV 281: The Salk legacy with Peter L. Salk

Apr 21, 2014

Peter L. Salk discusses the development of the first polio vaccine and Jonas Salk's legacy. Topics include childhood memories in Pittsburgh, career choices, challenges of vaccine testing, and the transition from oral to inactivated polio vaccine. The episode also explores the impact of a vaccine announcement on the scientist's family and the legacy of the Salk Institute.

Ask episode

Chapters

Transcript

Episode notes

Legacy of Dr. Jonas Salk and the Development of Vaccines

Memories of Moving to Pittsburgh and the Polio Vaccine Research

Family Influence and Career Choices

Early Days of Inactivated Polio Vaccine Development

13:58 • 17min

Reflections on the Impact of a Polio Vaccine Announcement

Development of Inactivated Poliovirus Vaccine and Legacy of Jonas Salk

39:43 • 21min

Human Population Growth and Polio Eradication Challenges

01:00:26 • 28min

Discussion on the upcoming centenary celebration and website update

01:28:25 • 2min